Mitch's Pool Service Fri, 25 Nov 2022 02:05:07 +0000 en-US hourly 1 Mitch's Pool Service 32 32 Coming to Shudder in December: Franchise Nightmare On Elm Street, Scare Package II, More Fri, 25 Nov 2022 00:49:58 +0000

Shudder turns up the horror in December with the Nightmare on Elm Street franchise, Scary Package II, and more. The service has announced next month’s lineup of additions, which also includes Shudder Originals Bloody Christmas Xmas and The excusenew episodes of Dragula: Titans and more.

You can see the full list below:

* Boulet Brothers Dragula: Titans – New Episodes Tuesday

Boulet Brothers’ Dragula: Titans brings together some of the most popular drag icons from the show’s previous seasons to compete in a grand championship of drag art and shocking physical challenges for a grand prize of one hundred thousand dollars, the head of the show. poster for the upcoming world tour and the first ever ‘Dragula Titans’ crown and title. Guest judges include Cassandra Peterson (Elvira), Harvey Guillen, Justin Simien, David Dastmalchian, Poppy, Alaska, Katya, Joe Bob Briggs, Bonnie Aarons, Barbara Crampton, and more. (A thrilling original series)

* Joe Bob’s Ghoultide Get-Together – Premiering Friday, Dec. 16 at 9 p.m. on Shudder TV and On Demand beginning Sunday, Dec. 18

Joe Bob is celebrating Christmas drive-in style, with The Last Drive-In’s third annual holiday auction, with proceeds going to charity. And who knows, this year’s double feature might even include a Christmas horror or two… (A Shudder Original)

* A Wounded Fawn – Premiering Thursday, December 1

Inspired by surreal art and Greek mythology, A Wounded Fawn follows the story of Meredith Tanning (Sarah Lind, The Humanity Bureau), a local museum curator who dips her toe in the dating pool, only to be targeted by a charming serial killer. (Josh Ruben, Scare Me). When a fateful romantic getaway between the two becomes a tense game of cat and mouse, the two must confront the madness within him. Written and directed by Travis Stevens (Jakob’s wife). (An original thrill)

* Bloody Christmas – Premieres Friday, December 9

It’s Christmas Eve and feisty record store owner Tori Tooms (Riley Dandy, That’s Amor) just wants to get drunk and party, until the robotic Santa Claus from a nearby toy store goes haywire and makes her night more than a little complicated. Santa goes on a rampant killing spree across the snowy neon landscape against a backdrop of drugs, sex, metal and violence, eventually forcing Tori into a blood-splattered battle for survival against the ruthless heavy metal Saint Nick himself. same. Also starring Sam Delich (Spiderhead), Jonah Ray Rodrigues (“Mystery Science Theater 3000”), Dora Madison (Alone with You), Jeremy Gardner (After Midnight), with Jeff Daniel Phillips (The Munsters) and Abraham Benrubi (“ER” ), written and directed by Joe Begos (VFW)(A Shudder Original)

* The Apology – Premieres Friday, December 16

Twenty years after her daughter’s disappearance, recovering alcoholic Darlene Hagan (Anna Gunn, Breaking Bad) prepares to throw her family’s Christmas party again with the help of her friend and neighbor, Gretchen (Janeane Garofalo , Wet Hot American Summer). Late on Christmas Eve, Jack (Linus Roache, Mandy), Darlene’s ex-brother-in-law, arrives unannounced, bearing nostalgic gifts and a dark secret. Soon, Darlene finds herself caught between sanity and ruthless instinct. Trapped together by a dangerous storm, a battle of wits escalates into a violent game of revenge. Written and directed by Alison Locke. (A Frisson exclusive)

* Scare Package II: Rad Chad’s Revenge – Premieres Thursday, December 22

When horror guru Rad Chad Buckley’s funeral turns into an elaborate series of deadly traps centered around Chad’s favorite movies, guests must band together and use the rules of horror to survive the bloody game. Core Story: Rad Chad’s Revenge directed by Aaron B. Koontz. Segments: Welcome to the 90’s directed by Alexandra Barreto, The Night He Came Back Again Part VI – The Night She Came Back directed by Anthony Cousins, Special Edition directed by Jed Shepherd, and We’re So Dead directed by Rachele Wiggins. (An original thrill)

* Burial – Premieres Thursday, December 29

In the final days of World War II, a band of Allied soldiers trafficking Hitler’s remains out of Germany are ambushed by Nazi Wehrwolf fighters. Directed by Ben Park and starring Charlotte Vega, Tom Felton, Harriet Walter, Barry Ward, Dan Renton Skinner and Bill Milner. (A Frisson exclusive)

One, two, Freddy is coming for you! Starting December 1, Shudder presents a collection of the first seven films in the A Nightmare on Elm Street franchise: Wes Craven’s original 1984 masterpiece, followed by Freddy’s Revenge (1985), Dream Warriors (1987), The Dream Master (1988), The Dream Child (1989), Freddy’s Dead: The Final Nightmare (1991) and Wes Craven’s New Nightmare (1994)

* A Nightmare on Elm Street (1984)

Can your nightmares be deadly? In this seminal slasher that launched a franchise, a horribly scarred pedophile who was murdered by a mob of lynchers returns years later to the terrifying nightmares of his killers’ children… And dreamy teenagers begin to die in their sleep.

* A Nightmare on Elm Street 2: Freddy’s Revenge

Freddy is back… and he wants revenge. When teenager Jesse Walsh moves to Elm Street, Freddy Krueger begins to appear in his nightmares. This time, Freddy takes possession of Jesse’s body whenever the teenager falls asleep, using Jesse to kill.

* A Nightmare on Elm Street 3: Dream Warriors

When local teenagers start dying, only Nancy Thompson knows the truth. Now a doctor at the local psychiatric hospital, she is the sole survivor of one of Freddy’s previous killings. Now it’s a fight against his co-workers’ disbelief and a race against time to stop Freddy before he kills again.

* A Nightmare on Elm Street 4: Master of Dreams

In Fourth Street Elm, Freddy Krueger (Robert Englund) returns to torment the Dream Warriors, forcing Kristen to bestow her powers on someone new.

* A Nightmare on Elm Street 5: The Dream Child

For five years, a walking nightmare named Freddy Krueger has haunted their sleep – seeking revenge for the horribly disfiguring death he suffered at the hands of the children’s parents. Now, through the dreams of an unborn child, Freddy has risen to life…and he’s looking for new victims.

* Freddy’s Dead: The Last Nightmare

In this sixth return to the horrifying world of Nightmare on Elm Street, the town of Springwood decides to end Freddy Krueger’s deadly grip on their dreams forever. Freddy finally confronts the one person he could never defeat, a psychologist who now discovers the source of his lifelong nightmares.

* Wes Craven’s New Nightmare

Ten years after writer and director Wes Craven brought his personal nightmares to the screen as Freddy Krueger in A Nightmare on Elm Street, the horrific child killer returns, stepping out of his celluloid world to haunt life. of the actress who defeated him for the first time on film.

Celebrate the season with Shudder’s “Unhappy Holidays” collection. New releases this month include Night of the Comet (12/1), Christmas Bloody Christmas (12/9), plus current Shudder titles Silent Night, Deadly Night Part 2, Silent Night, Deadly Night 3: Better Watch Out, Silent Night, Deadly Night 4: The Initiation, Silent Night, Deadly Night 5: The Toymaker, Have All A Good Night, Black Christmas (1974), Christmas Evil, Better Be Careful, A Story Of Christmas Horror, All Creatures Stirred, Christmas Presence, Deadly Games, Blood Beat, The Advent Calendar, A Creepshow Holiday Special, and The Christmas “Ghoul Log”.

1st December

* Comet Night

A huge comet passes near the earth, vaporizing almost the entire planet. Only a few teenagers (Catherine Mary Stewart, Kelli Maroney) survive – anyone outside has been ground to dust. But a few partially exposed people are now hideous, bloodthirsty zombies – and they begin a deadly hunt for the last remaining humans.

December 12

* The police blunder in the dark

During a spike in violent murders in the area targeting young women, a journalist searching for a missing friend ends up in a villa owned by an eccentric photographer.

* The killer is one of thirteen

A widow invites thirteen people to stay at her rural mansion. She reveals to them that she suspects the one who killed her husband must be one of them. Soon they too are being murdered one by one.

* Girl in room 2A

A sect of sadistic killers kidnaps and sacrifices beautiful women. A young girl, who has just been paroled, moves into an unfamiliar house and seems to be the cult’s next victim.

* French sex murders

A man is accused of killing his favorite prostitute in a French brothel. He is tried and sentenced to death. He tries to escape but dies during the chase. Soon the people connected to the case are being killed one by one.

* my dear killer

A mysterious beheading leads Inspector Peretti into a case of blackmail, deception and the unsolved kidnapping of a young girl.

* Autopsy

This grim giallo stars Mimsy Farmer (Four Flies on Gray Velvet) as a morgue worker who begins to investigate a series of suicides she suspects are actually murders. Helping him with the case is a priest who is prone to violent outbursts. Could his short fuse be because his sister was a recent victim – or is he the man behind the crimes? The only thing certain in this fast-paced horror film is that nothing is certain.

* murder mansion

A couple, lost in a thick fog, takes refuge in an old mansion next to a cemetery. Strange things start to happen.

* Mad Desires of a Murderer

A wealthy young girl invites some of her friends, including one she befriended on a recent trip to Asia, to her family mansion to spend the weekend there. Soon someone is horribly killed, and secrets and dark desires begin to unfold.

* Arabella black angel

Arabella is a nymphomaniac who has sex with any man. One day, her husband, a writer, meets her with another man. She has a strange reaction: kills the lover. Her husband hides the corpse. From then on, he encouraged her to meet other men and recorded her experiences in his new book.

* The killer is still among us

During a series of violent murders, a young woman writing a thesis in criminology begins to suspect that her new boyfriend, a medical examiner, might be a serial killer.

* Ursula’s sister

While searching for their estranged mother, two beautiful sisters, Dagmar and Ursula, arrive at a luxurious beachfront hotel. At the same time, a mysterious killer begins murdering promiscuous women in the area.

[ad_2]Source link

Water Treatment Equipment for Swimming Poor Market by Top Key Players – Hayward, Pentair, Fluidra, Culligan, CIPU, Prominent, Emaux, De Nora, Pahlen, MIURA, Hairunde, AQUA, Sterling, Speck Pump, Ozonetech, Zhengzhou Langjing, Intec America Thu, 24 Nov 2022 10:21:03 +0000

Scope and Overview of the Poor Swimming Water Treatment Equipment Market Report

The Swimming Water Treatment Equipment Market Research is an excellent resource for business experts, stakeholders, investors, VPs, and newcomers who want to learn more about the company and develop a competitive strategy. The latest market research studies the major factors influencing the expansion of the global market. Using the key market data provided in the report, market players can design strategies to strengthen their positions in the market.

Get a FREE sample report @

Main market players

  • Hayward
  • Pentair
  • Fluidra
  • Culligan
  • CIPU
  • Prominent
  • Enamels
  • From Nora
  • Pahlen
  • Hairunde
  • AQUA
  • Sterling
  • Point pump
  • Ozonetech
  • Zhengzhou Langjing
  • Intec America

The research uses a bottom-up methodology to collect and forecast data for a wide range of industry verticals and end-user industries, along with their reach across multiple categories, to estimate the overall size of process equipment. water for poor swimmers. market over the projected period. The market research report details Porter’s Five Forces analysis, important segments, drivers, opportunities and competitive environment.

Market Segmentation Analysis and Regional Overview

The report uses a bottom-up approach to collect and forecast data for a wide range of industry verticals and end-user industries, along with their scope across multiple categories, to estimate the overall size of Process Equipment water for poor swimmers. market over the forecast period. Geographical research by experts focuses on key countries and regions that have a significant impact on market revenue.

Water Treatment Equipment for Swimming Poor Market Segmentation, By Type

  • Traditional pool equipment
  • Wall-mounted pool equipment

Water Treatment Equipment for Poor Swimming Market Segmentation, By Application

Water Treatment Equipment for Swimming Poor Market Segmentation, By Region

  • North America [United States, Canada]
  • Europe [Germany, France, U.K., Italy, Russia]
  • Asia Pacific [China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia]
  • Latin America [Mexico, Brazil, Argentina]
  • Middle East and Africa [Turkey, Saudi Arabia, UAE]

Request a custom report based on your business needs @

Regional analysis

The Water Treatment Equipment for the Poor in Swimming market study delves into market factors such as total price estimates from major manufacturers and trends towards advancements in various regions of the world, putting focus on North America, Latin America, Europe, Asia-Pacific and the Middle East. East and Africa.

COVID-19 Impact Analysis

The COVID-19 pandemic has necessitated the development of new methods to prevent future occurrences while maintaining constant rates of progression. The market research report also provides advice on how to recover from pandemic-like events and mitigate their negative consequences. COVID-19 outbreak has had a significant impact on the Water Treatment Equipment for the Poor in Swimming market and research reports the wide coverage of its impact on different regions of the world.

Competitive analysis

The research report provides a comprehensive analysis of the global Water Treatment Equipment for Poor Swimmers Market and makes key recommendations for market players developing their strategies. To dominate the market, these companies have resorted to alliances, product development, joint ventures, mergers and acquisitions, diversification and joint ventures.

Top Reasons to Buy Water Treatment Equipment for Swimming Poor Market Report

– Experts have conducted geographical studies to identify important geographical regions and major nations that have a significant impact on market revenue.

– Market participants can use insights about prospects provided in the market research report to assess potential and make future plans.

Conclusion of the report

Business owners and policy makers can use the data from the market research report to decide which industry sectors to focus on in the coming years to plan investments and capitalize on the growing market for processing equipment. water for the poor in swimming.

Table of Contents – Analysis of Key Points

Chapter 1. Executive Summary

Chapter 2. Global Market Definition and Scope

Chapter 3. Global Market Dynamics

Chapter 4. Industry Analysis of Global Poor Swimming Water Treatment Equipment Market

Chapter 5. Water Treatment Equipment for Global Poor Swimming Market, By Type

Chapter 6. Water Treatment Equipment for Global Poor Swimming Market, By Application

Chapter 7. Water Treatment Equipment for Global Poor Swimming Market, Regional Analysis

Chapter 8. Competitive Intelligence

Chapter 9. Key Company Analysis

Chapter 10. Research Process


Buy this report @

Contact us:
Akash Anand
Head of business development and strategy
Telephone: +44 20 8144 2758

[ad_2]Source link

Leisure business grows with £2.4m funding Thu, 24 Nov 2022 08:17:38 +0000
Mark Greasley, Paul Armstrong, Ben Laing, Steve Sharp and Ben Lavin

A Burton on Trent-based leisure business has grown and created jobs after securing £2.4million in funding from HSBC UK.

Branston Golf and Country Club used a cash injection to help the business with its regeneration plans, following a management buyout before the Covid-19 pandemic.

The transformation includes the development of a health club, a 17m swimming pool, conference rooms, a nursery and a 2,000 square foot gymnasium, as well as extensive maintenance of several golf courses.

Branston Golf and Country Club has created ten corporate jobs, created to manage and support the promotion and operation of the club’s new and improved facilities.

Following its expansion, the company expects a 25% increase in turnover.

General Manager Ben Laing said: “The support from HSBC UK has allowed us to extend our investment over a longer period.

“Consolidating the investment into one package will allow us to increase the rate and volume of all revenue streams, resulting in steady and consistent growth across all business sections.

“As we operate in the premium segment of the market, this investment has enabled us to provide the highest quality of service and facilities to all of our members and customers.”

Paul Armstrong, Regional Director at HSBC UK, added: We are pleased to be able to support businesses in areas that are still recovering from the impact of the pandemic, such as Branston Golf and Country Club.

“The club is in a position to move forward with its exciting plans for future growth.”

[ad_2]Source link

Burton upon Trent Golf Club expands after securing funding Wed, 23 Nov 2022 09:06:02 +0000

A Burton upon Trent-based leisure business has grown with support from HSBC UK.

Branston Golf and Country Club has used a £2.4 million funding package from HSBC UK to help the business with its regeneration plans, following a management takeover of the club before the pandemic.

The transformation includes the development of a health club, a 17 meter swimming pool, conference rooms, a nursery and a 2,000 square foot gym, as well as extensive maintenance of several golf courses.

The Branston Golf and Country Club created 10 company-wide jobs, created to manage and support the promotion and operation of the club’s new and improved facilities.

With more than 3,000 members, Branston Golf and Country Club has seen a 23% increase in health and fitness memberships – and a 14% increase in golf memberships – since reopening after the pandemic in 2021.

Following its expansion, Branston Golf and Country Club expects a 25% increase in turnover to reach £5million in revenue at the end of a five-year regeneration plan.

Ben Laing, Managing Director of Branston Golf and Country Club, said: “The support from HSBC UK has allowed us to extend our investment over a longer period. Consolidating the investment into one package will allow us to drive the rate and volume of all revenue streams, resulting in steady and consistent growth across all business sections. As we operate in the premium segment of the market, this investment has enabled us to provide the highest quality of service and facilities to all of our members and customers.

Paul Armstrong, Regional Director at HSBC UK, added: “We are delighted to be able to support businesses in sectors that are still recovering from the impact of the pandemic, such as Branston Golf and Country Club. The Club is well positioned to move forward with its exciting plans for future growth.

The proposal was presented by Ben Lavin of Empire Finance who worked with Mark Greasley, Relationship Manager at HSBC UK, to find a suitable financial package.

[ad_2]Source link

Atrial Fibrillation Treatment Market to Witness Rapid Rise in Consumption During 2022-2030 Tue, 22 Nov 2022 05:18:41 +0000

Pune, Maharashtra, Nov 22 2022 (Wiredrelease) –:Global Atrial Fibrillation Treatment Market was valued at US$2.7 Billion in 2021 and is expected to reach US$16.4 Billion by 2022 -2030.

Global Atrial Fibrillation Treatment Market Study with 100+ Market Data Tables, Pie Chart, Graphs and Figures is now available at Market.Biz. This report provides a comprehensive assessment of the market, including future trends, growth factors, mindful opinions, and facts. It also includes industry-validated forecast data for 2030. Know your market! This is not only important for new products, but also for existing products due to ever-changing market dynamics. This study helps marketers stay on top of consumer trends and segmentation to avoid decline in Atrial Fibrillation Treatment market share.

Atrial fibrillation is a heart condition that causes the upper chambers of the heart (the atria) to quiver instead of beat efficiently. This can lead to blood pooling in the atria and clots forming. If a clot breaks off and enters the bloodstream, it can travel to the brain and cause a stroke.

Get sample copy of this report:

Atrial fibrillation is treated with medication, surgery, or a combination of both. Medications used to treat atrial fibrillation include beta blockers, calcium channel blockers, and antiarrhythmics. Surgical options include catheter ablation (destroying abnormal tissue with heat or cold), maze procedure (creating scar tissue to block abnormal electrical signals), and pulmonary vein isolation (removing tissue around pulmonary veins).

Effect of the war against Russia and Ukraine on the world market:

Businesses in Russia and Ukraine suffered significant losses due to the war between Russia and Ukraine. Many businesses in Ukraine have had to close due to the destruction of their infrastructure and the fighting. The economy has suffered as the unemployed are less likely to spend their money. Ukraine’s economy has been hit hard by Russia’s annexation and the closure of the Crimean market. Businesses in Russia find it difficult to import goods or materials due to sanctions imposed by the West. This caused inflation and a decline in the standard of living. However, some Russian companies managed to adapt to the new environment and even thrive.

Leading Segment of Atrial Fibrillation Treatment Market:

Key Product Types covered in the Atrial Fibrillation Treatment Market report:

Non-surgical procedures
Surgical interventions

The Atrial Fibrillation Treatment Market report includes the following applications:

Ambulatory surgery centers

Atrial Fibrillation Treatment Market Report Includes Key Players:

Johnson & Johnson
Scientific Boston
Koninklijke Philips
MicroPort Scientific
Sichuan Jinjiang Electronic Science and Technology

Effect of COVID-19 on Global Ohe Market:

Businesses around the world have suffered heavy losses due to the COVID-19 pandemic. Due to the spread of the virus, many businesses have been forced to close. Many companies have seen a significant drop in revenue and widespread layoffs as a result. Businesses have also faced new challenges due to the pandemic, including how to protect employees and adapt to changing customer demands. Some businesses can adapt to the new environment and thrive despite these challenges.

You can buy this report here:

Following are the segments of the global atrial fibrillation treatment market based on geography:

• North America (United States of America, Canada and Mexico)

• Asia-Pacific (Japan, China, India, Australia, etc.)

• Europe (Germany, UK, France, etc.)

• Central and South America (Brazil, Argentina, etc.)

• Middle East and Africa (United Arab Emirates, Saudi Arabia, South Africa, etc.)

This atrial fibrillation treatment market study answers the following questions:

1. What is the buying behavior of Atrial Fibrillation Treatment customers in a specific region?

2. What is the maximum amount a client can spend to invest in the treatment of atrial fibrillation?

3. What are the main factors driving the demand for products in the future compared to the present?

4. How does technological preference for the treatment of atrial fibrillation change consumer behavior?

5. Which atrial fibrillation treatment messages have the greatest impact?

6. What is driving the product change?

7. What technological advances have had an impact on the criteria for selecting suppliers?

Reasons to Buy this Atrial Fibrillation Treatment Market Report:

1. Study how mergers or acquisitions should be planned. This includes identifying the best manufacturer in the atrial fibrillation treatment market.

2. Targeting potential new customers or partners in the Atrial Fibrillation Treatment market according to your interests can help you reach new customers.

3. This atrial fibrillation treatment tool can provide high quality data analysis and support for internal and external presentations.

4. The Atrial Fibrillation Treatment research report can be used to help you develop tactical strategies by understanding the potential impact of big business.

If you have any questions about this report, please contact us:

Contact us:

420 lexington ave office 300

new york city, new york 10170.

phone: +1 (857) 4450045



This content was published by company. WiredRelease’s news service was not involved in the creation of this content. For press release service inquiries, please contact us at

[ad_2]Source link

Only a quarter of Pfizer’s COVID-19 treatment orders will go to developing countries Mon, 21 Nov 2022 15:37:14 +0000


Some countries could pay ten times the price of the generic equivalent of Paxlovid, as WHO chief calls for access to treatment to fight acute and long-lasting COVID-19

Rich countries got nearly three times as many courses of a World Health Organization (WHO)-recommended COVID-19 drug, Pfizer’s Paxlovid, according to a new analysis from Oxfam and the People’s Vaccine Alliance .

Using new data from Airfinity, organizations have found that only a quarter of treatment orders will go to low- and middle-income countries, despite the fact that they represent 84% of the world’s population and have a much greater need. regarding fewer people are vaccinated against COVID, unlike wealthy nations who are largely protected.

On the eve of tense talks at the World Trade Organization (WTO) over intellectual property rules for COVID-19 treatments and tests, campaigners warn we are seeing the same worrying trend of inequality we have seen with COVID vaccines.

Pfizer’s monopoly also means some middle-income countries could pay ten times more for Paxlovid than a generic equivalent, with reports of them being quoted up to $250 per course. This despite the fact that other low-income countries will have access to a Clinton Health Initiative (CHAI) deal with Pfizer and undisclosed generic companies, which means they could access the treatment for just $25 per Classes.

“When vaccines were our main medical tool to fight COVID-19, big pharma prioritized maximizing their profits by selling doses to wealthier countries,” said Dr. Catherine Kobutungi, executive director. from the African Center for Population and Health Research. “Millions of people died as people in low- and middle-income countries were sent to the back of the vaccine queue. And now we are seeing a repeat of the same inequity with COVID-19 treatments and testing. »

“Oral antiviral treatments are easy to administer. They reduce hospitalizations and deaths. And they can reduce the likelihood of a long COVID. Yet, at present, they are almost exclusively accessible to people in the wealthiest countries,” she added. “The fact is, if you are a vulnerable person with COVID-19 in a high-income country, you will likely have access to treatments that can help you survive. If you live in a low-income country, you probably won’t. It’s a grotesque inequality and it kills.

WHO recommends using Paxlovid to reduce COVID-19 hospitalization and death rates, and called for equitable global access to COVID-19 drugs as part of a long COVID strategy . A recent unexamined study suggests that Paxlovid may reduce the risk of patients developing long COVID.

There are hundreds of other potential COVID-19 drugs in development, including at least 77 in late-stage clinical trials that may be more effective and have a wider scope of use. However, intellectual property rules give a small number of companies a monopoly over supply, distribution and price, which means that low- and middle-income countries are unlikely to have affordable access to Neither do these drugs.

Because far fewer people in low-income countries are vaccinated than in rich countries, they are more vulnerable to hospitalization and death from COVID-19. These countries have already seen the highest death toll of the pandemic, a trend that could continue without access to treatments like Paxlovid.

“After the inequity they faced with the rollout of the vaccine, developing countries are now facing issues of access and affordability for COVID treatments. It’s a shame that those who need it the most receive the fewest and that patent laws give Pfizer a long monopoly on this life-saving drug,” said Jennifer Reid, senior health and vaccine equity adviser at Oxfam. Tackling both acute COVID and long COVID is essential – and the WHO has made it clear that countries need treatments like Paxlovid to reduce deaths and hospitalizations. But the patent minefield is a huge obstacle preventing many developing countries from getting the medicines and tests they need now and in the future to save lives.

In June, after a year and a half of negotiations, the WTO rejected proposals to waive intellectual property rules for all COVID-19 medical technologies, adopting a much more limited text that only covers vaccines. Ahead of talks in Geneva tomorrow, civil society organizations are urging WTO member states to immediately agree to an extension to include treatment and testing, which would allow developing countries to produce for their own populations and export for others in need, ensuring essential tools are accessible and affordable.

“Decades ago, governments allowed pharmaceutical companies to control the price, allocation and supply of life-saving HIV drugs – and millions died without affordable access,” said Mohga Kamal Yanni, People’s Vaccine Alliance Policy Co-Chair. “Now the same is happening with COVID-19 vaccines and drugs. Corporations have been allowed to decide who lives and who dies. WTO member states must ensure that public health takes precedence over commercial interest.


Notes to Editors

A new People’s Vaccine Alliance briefing note on the case for extending the WTO Ministerial Decision to therapeutics and diagnostics is available here:

Data from Airfinity shows that the wealthiest countries which represent only 16% of the world’s population will receive 74% of all courses ordered from Paxlovid. Low- and middle-income countries that represent 84% of the world’s population will receive only 26%. Although it was first authorized in December 2021, reports suggest few doses are available to people in low- and middle-income countries.

Although there is little data available on how many doses of Pfizer’s antiviral treatment have actually been delivered to low- and middle-income countries, they have been waiting for months to receive doses through Paxlovid supply agreements d global initiatives like UNICEF and the Global Fund. Pfizer reportedly insisted that the prices of these agreements remain secret, and the initiatives did not reveal the prices charged by Pfizer for the courses under their agreements.

Data Note: These figures reflect agreements with Pfizer. A number of generic manufacturers believed to produce Paxlovid have signed agreements through the Medicines Patent Pool. However, these agreements are not expected to produce/export finished pharmaceuticals on a large scale until early 2023.

  • According to the World Intellectual Property Organization (WIPO), there are at least 1,465 patents on treatments and 417 on vaccines for COVID-19, making it a “minefield” for developing countries.
  • Two years ago, South Africa and India proposed a waiver from the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) for medical technologies related to COVID-19, including vaccines, tests and treatments. The waiver was backed by more than 100 low- and middle-income countries, but was blocked by a small number of wealthy countries, including the EU, UK and Switzerland.
  • After 18 months, the WTO finally decided in June 2022 to streamline existing rights to use compulsory licenses to produce generic COVID-19 vaccines for domestic use and for export without authorization from the patent holder. . The June decision required member states to reach a decision on testing and treatment by December 2022. Negotiations to reach a decision on testing and treatment are ongoing. The WTO TRIPS Council will then meet on Tuesday 22 November.
  • A selection of letters sent to WTO member states, urging them to support extending the June decision to cover treatment and testing, can be found here:
  • Fulfillment of UNICEF’s Paxlovid order reportedly delayed for several months:
  • A Global Fund agreement for Paxlovid was not finalized until late September: pfizer-to -expand-access-to-paxlovid-antiviral/
  • Pfizer allegedly pressured UNICEF to keep Paxlovid pricing secret:
  • According to BIO’s COVID-19 Therapeutic Development Tracker, there are 77 antivirals and treatments in the “advanced clinical” phase as of November 14: pipeline tracker
  • Reports indicate that many countries classified at the WTO as “developing” and “least developed” remain unable to access affordable treatment in the volumes needed. A report by the ACT-Accelerator Facilitation Council Task Force finds that “equitable deployment of COVID-19 diagnostics and treatments continues to be inadequate and threatens to undo public health gains made throughout the pandemic”. Nature similarly says, “Limited supplies and high costs have limited the flow of COVID-19 antivirals to low- and middle-income regions.”
  • Pharmaceutical companies say licensing deals and donations announced in recent months will ensure doses reach low-income countries, but those deals exclude many developing countries, particularly in Latin America. This is despite Latin America accounting for a large share of estimated preventable COVID-19 deaths worldwide.
  • Four times as many people have died from COVID-19 in low-income countries than in rich countries. Per capita deaths in low and lower middle income countries are almost a third higher than in high income countries: -toll-four-times -higher-in-poorer-than-richer-countries/
  • According to the World Intellectual Property Organization (WIPO), there are at least 1,465 patents on treatments and 417 on vaccines for COVID-19: wipo-pub-1075-en-covid-19-related-vaccins-and-therapeutics.pdf
[ad_2]Source link

Marine North Berwick offers a Sunday Dine and Unwind Package Mon, 21 Nov 2022 10:21:25 +0000
North Berwick Marine Spa Photo: A Baxter

“Do you want access to the spa before or after Sunday lunch?” they asked, at Marine North Berwick.

There is only one sensible answer to this question.

No one wants to be seen in a bathing suit after getting their face stuffed. I would look like Moby Dick. It would scare the other guests.

We were taking advantage of the new Sunday Dine and Unwind package at this hotel in East Lothian. If you eat from the Sunday menu, with no minimum spend, they will receive two hours of free access to the spa.

We arrived at 11am, to take full advantage of our time. It’s not my first visit here, and the spa, which now offers treatments by French brand Caudalie, is much as I remember, although the 19th-century Victorian golf hotel has been taken over by the American company Marine & Lawn last year.

There is the pool, but we skipped that as we didn’t plan on exercising. However, there’s also a bubbly hydropool, which extends outdoors, and features a gooseneck fountain and tiled beds.

Inside, you will find two saunas, one of which is infra-red, a pair of hammams, massage showers and an ice fountain to refresh you. We went around each one, twice.

Although we had lunch reservations at 1pm, something about North Berwick’s air-combined heat treatments whetted our appetites. Fortunately, The Lawn restaurant was able to seat us earlier, at 12:30.

There seemed to be quite a few other tables taking advantage of the deal. We identified them by their rosy cheeks and wet hair.

There is a good selection of dishes on the Sunday lunch menu. We both had the citrus cured salmon starters (£11) which were great, but we should have skipped the forerunner and gone straight to the roast beef (£22) as it had such a monolithic portion. You really don’t need anything else.

We each had three huge slices of dry aged Scottish roast beef, duck fat roast potatoes, herb carrot, creamed greens, horseradish sauce, heaps of gravy and coppery Yorkshire puddings that were so huge we could have sailed to the Bass Rock in them. There are other options to choose from, such as plaice (£24) and truffle macaroni and cheese (£14), but unless you’re vegetarian or vegan why would you want anything else when they do an excellent plate like that?

Puddings include sticky toffee (£8) or apple tart tatin (£8), but we were full.

That’s so much, with no closing date. Remember to eat after the spa, not before.

[ad_2]Source link

10-day-old baby seal transferred to Athens for treatment (PHOTOS) Sun, 20 Nov 2022 11:15:50 +0000

An orphan seal pup aged just 10 days was found on a beach in Crete in early November and traveled to Athens to be cared for by the Society for the Study and Protection of the Mediterranean Seal (MOM) until that it is old enough to be released into its natural environment.

Port authorities, who located the seal with the help of local people, contacted the organization for instructions on how to properly handle the incident to keep the animal safe.

The Society for the Study and Protection of the Mediterranean Seal – MOM was founded in 1988 and has been taking care of orphaned or sick seals since 1990 until today.

“This year we have two little ones. Hermes was found in October at Pili in Euboea and now in November Minos has come to us from Crete, from Sitia,” MOM biologist Eleni Tounda told AMNA.

“Both are babies, this is when they would normally be breastfed by their mothers but they got carried away by the storms, they were sick too.

“We give medicines in consultation with the veterinarian in charge and we hope that after the three months we have them here, we will release them back into their natural environment, as we do every time.”

2 21

3 14

4 8

The seal, which was named Minoas because it was spotted in Sitia, is housed in specially designed areas and a swimming pool where it is monitored by a veterinarian and cared for daily by MOM specialists.

Weighing, bathing, gradually changing from fish paste to training to learn how to eat fish and how to swim are on the daily program of the baby who keeps company with Hermès, also an orphan seal spotted in October in Euboea.

As Ms. Tounda explains, “because the seals are at an age where they would suckle from their mothers, we now feed them fish paste with essential vitamins, until they move on to the next stage, which will be to give them fish to eat. And after they reach about 60 kilograms and learn to eat fish, we release them.”

Seals are wild mammals and when they approach beaches or harbors it is extremely important for their own welfare and survival that people avoid contact with them.

Citizens, if they spot seals, are asked to move away, not to seek contact and, of course, not to feed them. If they think the animal may be in trouble, they are advised to call the Port Authority and MOM immediately.

READ MORE: The first Tesla store in Greece opens on Monday!